Sujit Bhayani has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
SUDEEPPHRM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Sudeep Pharma's promoters and promoter group have disclosed holding 8,60,12,797 equity shares, representing 76.15% of the company's total shareholding as of 31st March, 2026. The disclosure explicitly confirms that NIL (zero) shares are encumbered or pledged by the promoters. This is a routine periodic compliance filing under SEBI regulations requiring promoters to declare their shareholding status. The promoter group includes 41 entities spanning individuals, HUFs, private companies, LLPs, and trusts.
Promoters maintaining a strong 76.15% stake with zero pledged shares indicates a healthy promoter position with no immediate dilution risk or encumbrance concerns for shareholders.